Ambey Laboratories IPO description – Ambey Laboratories has been dedicated to the manufacturing of agrochemical products for crop protection for nearly four decades. The company specializes in producing and supplying “2, 4-D base chemicals,” adhering to the highest quality standards and complying with the stringent Environmental, Health, and Safety (EHS) regulations in the chemical industry.
The company’s manufacturing facility in Behror, Rajasthan, is certified with ISO 9001:2015 by the Quality Research Organization and ISO 14001:2015 by the United Accreditation Foundation. As of 31 January 2024, the company employs 195 people in various departments.
Currently, the company produces an array of chemicals: 2,4-D Acid 98% TC, 2,4-D Sodium 95% SP, 2,4-D Amine in concentrations of 866, 720, and 480g/l SL, 2,4-D Ethyl Hexyl Ester 96% TC, and 2,4-D Ethyl Ester 96% TC. Their product line also includes Chlorpyriphos available in 97% TC, 20% EC, and 50% EC formulations, Thiamethoxam in 96% TC, 25% WG, and 75% SG, Pretilachlor in 95% TC, 50% EC, and 37% EW, Metribuzin at 97% TC and 70% WS, Hexaconazole in 92% TC, 5% SC, 5% EC, and 10% EC, and Metalaxyl at 98% TC and 35% WS. These products serve a diverse clientele, including major corporations such as Aromatic Rasayan Private Limited, JR Jindal Infraprojects Private Limited, and SC Formulator Co. Ltd.
Promoters of Ambey Laboratories – Archit Gupta, Arpit Gupta, Sarina Gupta and Rishita Gupta
Table of Contents
Ambey Lab IPO Details
| Ambey Laboratories IPO Dates | 4 – 8 July 2024 |
| Ambey Laboratories Issue Price | INR 65 – 68 per share |
| Fresh issue | 62,58,000 shares (INR 40.68 – 42.55 crore) |
| Offer For Sale | 3,12,000 shares (INR 2.03 – 2.12 crore) |
| Total IPO size | 65,70,000 shares (INR 42.71 – 44.68 crore) |
| Minimum bid (lot size) | 2,000 shares (INR 1,36,000) |
| Face Value | INR 10 per share |
| Retail Allocation | 35% |
| Listing On | NSE Emerge |
Ambey Laboratories Financial Performance
| FY 2021 | FY 2022 | FY 2023 | 10M FY 2024 | |
| Revenue | 81.74 | 84.60 | 104.82 | 100.32 |
| Expenses | 72.01 | 74.26 | 96.41 | 87.64 |
| Net income | 10.34 | 3.57 | 4.57 | 6.08 |
Ambey Laboratories Offer News
- Ambey Laboratories RHP
- Ambey Laboratories Draft Prospectus
- ASBA IPO Forms
- Live IPO Subscription Status
- Highest SME IPO Subscription in 2024
Ambey Laboratories Valuations & Margins
| FY 2021 | FY 2022 | FY 2023 | |
| EPS | 21.12 | 7.08 | 2.57 |
| PE ratio | – | – | 25.29 – 26.46 |
| RONW (%) | (80.84) | 63.82 | 21.40 |
| NAV | (16.07) | 37.78 | 13.32 |
| ROCE (%) | 58.51 | 12.53 | 12.75 |
| EBITDA (%) | 12.73 | 12.83 | 10.52 |
| Debt/Equity | (4.19) | 0.95 | 0.58 |
Ambey Laboratories IPO GMP Today
| Date | Consolidated IPO GMP | Kostak | Subject to Sauda |
| 10 July 2024 | 40 | – | 52,000 |
| 9 July 2024 | 40 | – | 52,000 |
| 8 July 2024 | 45 | – | 57,000 |
| 6 July 2024 | 45 | – | 57,000 |
| 5 July 2024 | 50 | – | 58,000 |
| 4 July 2024 | 33 | – | 50,000 |
| 3 July 2024 | 20 | – | 33,500 |
| 2 July 2024 | 20 | – | 33,500 |
Ambey Laboratories IPO Subscription – Live Updates
| Category | QIB | NII | Retail | Total |
|---|---|---|---|---|
| Shares Offered | 12,52,000 | 9,36,000 | 21,84,000 | 43,72,000 |
| 8 Jul 2024 | 61.90 | 210.13 | 194.18 | 319.43 |
| 5 Jul 2024 | 0.41 | 32.82 | 64.04 | 78.27 |
| 4 Jul 2024 | 0.41 | 12.69 | 27.62 | 33.26 |
The market maker reservation portion of 3,30,000 shares and anchor allocation portion of 18,68,000 shares is not included in the above calculations.
Ambey Laboratories IPO Allotment Status
Ambey Laboratories IPO allotment status is now available on Link Intime’s website. Click on Link Intime IPO weblink to get allotment status.
Ambey Laboratories IPO Dates & Listing Performance
| IPO Opening Date | 4 July 2024 |
| IPO Closing Date | 8 July 2024 |
| Finalization of Basis of Allotment | 9 July 2024 |
| Initiation of refunds | 10 July 2024 |
| Transfer of shares to demat accounts | 10 July 2024 |
| IPO Listing Date | 11 July 2024 |
| Opening Price on NSE SME | INR 85 per share (up 25%) |
| Closing Price on NSE SME | INR 89.25 per share (up 31.25%) |
Ambey Laboratories Offer Lead Manager
FAST TRACK FINSEC PRIVATE LIMITED
Office No. V-116, 1st Floor, New Delhi House, 27,
Barakhamba Road, New Delhi – 110001
Phone: +91 11 43029809
Email: [email protected] / [email protected]
Website: www.ftfinsec.com
Ambey Laboratories Offer Registrar
LINK INTIME INDIA PRIVATE LIMITED
C-101, 1st Floor, 247 Park L.B.S. Marg,
Vikhroli West, Mumbai – 400 083, Maharashtra
Telephone: +91 810 811 4949
Email: [email protected]
Website: www.linkintime.co.in
Ambey Laboratories Issue Contact Details
AMBEY LABORATORIES LIMITED
Ground Floor, Property No.555 Tarla Mohalla,
Ghitorni, South West Delhi, New Delhi -110030
Phone: 0124-4000788
E-mail: [email protected]
Website: ambeylab.com
IPO FAQs
What is the Ambey Laboratories’ offer size?
Ambey Laboratories’ offer size is INR 42.71 – 44.68 crores.
What is the Ambey Laboratories offer price band?
Ambey Laboratories public offer price is INR 65 – 68 per share.
What is the lot size of the Ambey Laboratories IPO?
Ambey Laboratories offer a lot size is 2,000 shares.
What is Ambey Laboratories IPO GMP today?
Ambey Laboratories IPO GMP today is INR 40 per share.
What is the Ambey Laboratories kostak rate today?
Ambey Laboratories kostak rate today is INR NA per application.
What is Ambey Laboratories Subject to the Sauda rate today?
Ambey Laboratories is Subject to the Sauda rate today is INR 52,000 per application.
